Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2005
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/06/2005WO2005093083A1 Method of disease prediction and method of using the same
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005092898A1 The conjugates of a hydrophilic polymer-tripterygium's extracts and the pharmaceutical compositions thereof
10/06/2005WO2005092355A1 Phyto-composition for the treatment of articular diseases
10/06/2005WO2005092349A1 Insulin resistance improving agent
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005WO2005092322A1 Natural compound causing rar activation
10/06/2005WO2005092320A1 Cytoprotective composition
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222238 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222153 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222114 Use of new etonogestrel esters
10/06/2005US20050222100 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
10/06/2005US20050222010 Composition for treating or preventing hyperuricemia
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050220894 Colostrum-based composition
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2560927A1 Insulin resistance-improving agent
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582520A1 Novel parp inhibitors
10/05/2005EP1582208A2 An amino acid compositions for promoting collagen synthesis
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1678744A Human antihuman interleukin-6 antibody and fragment of the antibody
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678575A Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678327A Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676156A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676155A Chinese medicine composition for treating rheumatism
10/05/2005CN1676154A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676153A Chinese medicine composition for treating rheumatic rheumatoid arthritis
10/05/2005CN1676150A Bone-setting qili formulation for treating traumatic injury
10/05/2005CN1676143A Chinese medicine compound formulation for treating rheumatism
10/05/2005CN1676139A Plaster for treating protrasion of the lumber intervertebral disci
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221182C Synanthrin products with improved nutritional properties
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951850 Dipeptide derivatives
09/2005
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005089810A1 Method of inducing bone by transferring human osteogenetic factor gene with the use of electroporation method
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089800A1 PHARMACEUTICAL COMPOSITION CONTAINING hsHRD3
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2004041758A8 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics
09/29/2005US20050215640 HMB compositions and uses thereof
1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 820